EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Vedolizumab use for severe chronic enterocolitis in a child with Hoyeraal–Hreidarsson syndrome: A case report

Yasutaka Chiba, Manabu Takahashi iD, Taro Yoshida, Seiya Tagane, Takeshi Shiohata, Shoko Miura, Manami Akasaka

JPGN Reports · 29.10.2026

DOI: 10.1002/jpr3.70291 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JPGN Reports, online erschienen am 29.10.2026. Verfasst von Yasutaka Chiba und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics Iwate Medical University Yahaba Japan. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a patient with Hoyeraal–Hreidarsson syndrome (HHS), a telomere biology disorder, who developed severe chronic enterocolitis with inflammatory bowel disease‐like features. Vedolizumab led to improvement in stool frequency, reduced fecal calprotectin, and clinical remission without infectious complications. Remission was maintained with vedolizumab monotherapy for 2 years after discontinuation of budesonide and parenteral nutrition. This report highlights vedolizumab as a potentially safe therapeutic option for enterocolitis in HHS, emphasizing the value of gut‐selective therapy when systemic immunosuppression is risky. Further studies are needed to establish the long‐term efficacy and safety of vedolizumab in patients with telomere biology disorders.

Schlagwörter

Stichwörter der Autor:innen

RTEL1 mutationgut‐selective therapytelomere biology

Autor:innen und Institutionen

  • Department of Pediatrics Iwate Medical University Yahaba Japan.

ORCID-Profile: Manabu Takahashi

Zitieren

APA

Chiba, Y., Takahashi, M., Yoshida, T., Tagane, S., Shiohata, T., Miura, S., & Akasaka, M. (2026). Vedolizumab use for severe chronic enterocolitis in a child with Hoyeraal–Hreidarsson syndrome: A case report. JPGN Reports. https://doi.org/10.1002/jpr3.70291

Vancouver

Chiba Y, Takahashi M, Yoshida T, Tagane S, Shiohata T, Miura S, et al. Vedolizumab use for severe chronic enterocolitis in a child with Hoyeraal–Hreidarsson syndrome: A case report. JPGN Reports. 2026. doi:10.1002/jpr3.70291

BibTeX
@article{Chiba2026,
  author = {Chiba, Yasutaka and Takahashi, Manabu and Yoshida, Taro and Tagane, Seiya and Shiohata, Takeshi and Miura, Shoko and Akasaka, Manami},
  title = {Vedolizumab use for severe chronic enterocolitis in a child with Hoyeraal–Hreidarsson syndrome: A case report},
  journal = {JPGN Reports},
  year = {2026},
  doi = {10.1002/jpr3.70291}
}
Kostenlos starten →